The importance of COX-2 inhibition for aspirin induced asthma

Thorax

Volumn 55, Issue SUPPL. 2, 2000, Pages

  Bennett, Alan ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; KETOPROFEN; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

ASTHMA; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0033806439     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.suppl_2.s54     Document Type: Conference Paper

References (27)

1. 1 Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
2. 2 Gryglewski RJ. Aspirin-induced asthma and cyclooxygenases. In: Vane J, Botting J, eds. Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential. William Harvey Press and Kluwer Academic Publishers, 1998: 99-107.
3. 3 Senna GE, Passalacqua G, Andri G, et al. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Safety 1996;14:94-103.
4. 4 Bennett A. Overview of nimesulide. Rheumatology 1999; 38(Suppl 1):1-3.
5. 5 Bennett A, Villa G. Nimesulide: a nonsteroidal anti-inflammatory drug that preferentially inhibits cyclooxygenase-2, and has various unique pharmacological activities. Expert Opinion on Pharmacotherapy 2000;1:277-86.
6. 6 Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996;154: 1608-14.
7. 7 Bennett A, Berti F, Ferreira SH. Nimesulide: a multifactorial therapeutic approach to the inflammatory process? Drugs 1993;46 (Suppl 1).
8. 8 Tavares IA, Bishai PM, Bennett A, Activity of nimesulide on constitutive and inducible cyclo-oxygenases. Arzneimittel-Forschung 1995;45:1093-6.
9. 9 Famaey J-P. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res 1997;46:437-46.
10. 10 Shah AA, Murray FE, Fitzgerald DJ. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity. Rheumatology 1999;38(Suppl 1):19-23.
11. 11 Magni E. The effect of nimesulide on prostanoid formation. Drugs 1993;46(Suppl 1):10-14.
12. 12 Robuschi M, Refini M, Sturman et al. La nimesulide non induce asma in pazienti asmatici FANS intolleranti. Proceedings of an International Symposium on Advances in Pneumology and Cardiology. Bologna: Monduzzi Publishers, 1987: 431-5.
13. 13 Bianco S, Robuschi M, Petrigni G et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993;46 (Suppl 1):115-20.
14. 14 Bilancia R, Ferranini A, Chianese R, et al. Nimesulide tolerance in ASA-induced asthma. In: Basomba A, Sastre J, eds. Proceedings of XVI European Congress of Allergology and Clinical Immunology. Bologna: Monduzzi Publishers, 1995: 559-62.
15. 15 Faria E, Tomas MR, Carrapatoso JA, et al. Could nimesulide be an alternative in aspirin hypersensitivity patients? Allergy 1996;51 (Suppl 31):57.
16. 16 Astarita C, Franzese A, Sproviero S, et al. Epidemiologia delle reazioni avverse ai farmaci antiifiammatori non steroidei. La nimesulide e tollerata dai pazienti con reazioni avverse ai FANS e modula nell'uomo la riposta cutanea all'istamina ed alla codeina. Recenti Prog Med 1992;83:567-71.
17. 17 Muratore L, Ferraranini A, Toraldo MD, et al. Studio controllato sulla tollerabilita della nimesulide in pazenti con manifestazioni cutanee da intolleranza ad ASA e FANS. G Ital Allergol Immunol Clin 1992;2:157-62.
18. 18 Ispano M, Fontana A, Scibilia J, et al. Oral challenge with alternative non steroidal antiinflammatory drugs and paracetamol in patients intolerant to these agents. Drugs 1993; 46(Suppl 1):253-6.
19. 19 Andri L, Senna GE, Andri G, et al. Impiego della nimesulide in soggetti con intolleranza agli antiinfiammatori non steroidi. Folia Allergol Immunol Clin 1990;37:93-7.
20. 20 Andri L, Senna GE, Betelli C, et al. Tolerability of nimesulide in aspirin sensitive patients. Ann Allergy 1994;72:29-32.
21. 21 Bernstein M, Rodriguez C. Challenge with nimesulide, a new NSAID, in patients with reactions to aspirin and other NSAIDs (absrract). J Allergy Clin Immunol 1996;97:345.
22. 22 Kosnik M, Music E, Matjaz F, et al. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998;53:1231-3.
23. 23 Ottonello L, Dapino P, Pastorino G, et al. Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers. J Clin Lab Immunol 1992;37:91-6.
24. 24 Berti F, Rossoni G, Buschi A, et al. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig. Arzneimittel-Forschung 1900;40:1011-6.
25. 25 Rossoni G, Berti F, Buschi A, et al. New data concerning the antianaphylactic and antihistaminic activity of nimesulide. Drugs 1993;46(Suppl 1):22-8.
26. 26 Ferreira SH. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 1993;46(Suppl 1):1-9.
27. 27 Pelletier JP, Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs 1993;46(Suppl 1):34-9.